Letermovir in ART-treated HIV-infected Persons (clinicaltrials.gov) - Aug 1, 2025 - P=N/A | N=33 | Completed | Sponsor: Jean-Pierre Routy | Trial completion date: Jul 2025 ➔ Jan 2025 | Trial primary completion date: Jul 2025 ➔ Jan 2025
Trial completion date • Trial primary completion date • Human Immunodeficiency Virus • Infectious Disease • Inflammation • Inflammatory Bowel Disease • CD4
|